Outsourcing

Articles

The company announced plans to construct a 1.3 million-ft2 integrated manufacturing center in Chengdu, China.

WuXi Biologics to Build New Manufacturing Center in China

Recipharm Inhalation Solutions is an integrated service for inhalation products.

Recipharm Launches Development and Manufacturing Service for Inhalation Products

The investment will increase patient-centric dosage form manufacturing capabilities at Catalent’s Winchester, KY, facility.

Catalent Invests $40 Million at Kentucky Manufacturing Facility

Expansion at the Eberbach, Germany facility includes two Vegicap encapsulation lines, printing, inspection, and packaging capabilities.

Catalent Invests $14 Million at Softgel Facility in Germany

A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.

Ajinomoto Bio-Pharma Services Expands Services

Joshua Zhang is head of WuXi STA’s Jinshan site.

Process optimization improves process mass intensity, reduces environmental impact, and improves cycle time for bio/pharmaceutical processes.

Improving Process Mass Intensity for Bio/Pharmaceutical Production

In a partnership with Thermo Fisher Scientific Pharma Services, Pacira added a manufacturing suite in Swindon, UK, that doubles the company’s capacity by mirroring the company’s facility in San Diego, CA. 

Pacira Pharmaceuticals Expands Manufacturing in UK

With the $252-million acquisition of contract development, manufacturing, and testing organization Avista Pharma Solutions, Cambrex will enter the market for early stage small-molecule development and testing services.

Cambrex to Acquire Avista Pharma

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Heightened uncertainty means CDMO executives need to play out planning scenarios.

What Ifs in the Five-Year Plan

The acquisition will place Cambrex into the finished dosage form CDMO market.

Contract Manufacturing, Finished Drug Product